Déwi Vernerey

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

Axel Grothey, Alberto Sobrero, Anthony F. Shields et al. · New England Journal of Medicine · 2018 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +16

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

Alexandre Loupy, Carmen Lefaucheur, Déwi Vernerey et al. · New England Journal of Medicine · 2013 · 833 citations · Full text

Life Sciences, Immunology, Surgery +17

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to <i>BRAF</i> Mutation and Mismatch Repair Status of the MOSAIC Study

Thierry André, Armand de Gramont, Déwi Vernerey et al. · Journal of Clinical Oncology · 2015 · 675 citations

Medicine, Molecular Genetics, Oncology +17

Antibody-mediated vascular rejection of kidney allografts: a population-based study

Carmen Lefaucheur, Alexandre Loupy, Déwi Vernerey et al. · The Lancet · 2012 · 332 citations

Life Sciences, Immunology, Nephrology +16

Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

Thierry André, Jeffrey A. Meyerhardt, Timothy Iveson et al. · The Lancet Oncology · 2020 · 298 citations

Medicine, Biostatistics, Oncology +13